Hanyu Pharmaceutical: 2021 pre-profit 25 million-37.5 million yuan year-on-year loss jqknews

Securities Times e company news, Hanyu Pharmaceutical (300199) announced on the evening of January 24 that it is expected that the net profit attributable to shareholders of listed companies in 2021 is 25 million yuan – 37.5 million yuan, compared with a loss of 609.4272 million yuan in the same period last year. The company’s equity accounting method for Jianhui Information was changed from equity method to fair value measurement, resulting in a substantial increase in investment income compared with the same period of the previous year. The state has continued to strengthen the control of drug prices, which has a great impact on the entire pharmaceutical industry. The gross profit margin of the company’s listed products has declined, resulting in negative operating profits.